Oncternal Therapeutics Inc (NAS:ONCT)
$ 8.635 0.08 (0.94%) Market Cap: 25.56 Mil Enterprise Value: -8.62 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 50/100

Q1 2020 Oncternal Therapeutics Inc Earnings Call Transcript

May 07, 2020 / 07:00PM GMT
Release Date Price: $50 (-5.87%)
Operator

Greetings, and welcome to the Oncternal Therapeutics Inc. First Quarter Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mr. Rich Vincent, Chief Financial Officer. Please go ahead, Mr. Vincent.

Richard G. Vincent
Oncternal Therapeutics, Inc. - CFO, Treasurer & Secretary

Thank you, operator. Good afternoon, everyone, and thank you for joining us. I'd like to welcome you to our Business Update and 2020 first quarter financial results conference call. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our Chief Medical Officer, Dr. Frank Hsu.

Today's call includes a business update and discussion of our 2020 first quarter results, which will be followed by Q&A. Please note that today's press release is available on the Investor Relations section of Oncternal's website. Earlier today, we filed our 10-Q for the first quarter 2020. A replay of today's earnings call will be available on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot